RFERENCES
1. Mannucci E, Silverii A, Monami M. Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy. International journal of clinical practice . Nov 24 2020:e13867. doi:10.1111/ijcp.13867
2. Ozcelik F, Tanoglu A, Guven BB, Keskin U, Kaplan M. Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a reflection of the innate immune status.International journal of clinical practice . Jul 12 2021:e14624. doi:10.1111/ijcp.14624
3. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. Jama . May 26 2020;323(20):2052-2059. doi:10.1001/jama.2020.6775
4. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine . Apr 30 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
5. Bertolini A, van de Peppel IP, Bodewes F, et al. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology . Nov 2020;72(5):1864-1872. doi:10.1002/hep.31480
6. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature . Nov 27 2003;426(6965):450-4. doi:10.1038/nature02145
7. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell . Apr 16 2020;181(2):271-280 e8. doi:10.1016/j.cell.2020.02.052
8. Ali N, Hossain K. Liver injury in severe COVID-19 infection: current insights and challenges. Expert review of gastroenterology & hepatology . Oct 2020;14(10):879-884. doi:10.1080/17474124.2020.1794812
9. Yang R, Gui X, Ke H, Gao S, Luo M, Xiong Y. The indicative role of markers for liver injury on the severity and prognosis of coronavirus disease 2019 patients. European journal of gastroenterology & hepatology . Oct 29 2020;doi:10.1097/MEG.0000000000001968
10. Organization WH. Assessment tool for laboratories implementing COVID-19 virus testing: interim guidance, 8 April 2020.https://apps.who.int/iris/handle/10665/331714
11. Bakanligi TCS. COVID-19 (SARS-CoV-2 ENFEKSİYONU) ERİŞKİN HASTA TEDAVİSİ. October 2020.https://covid19.saglik.gov.tr/TR-66926/eriskin-hasta-tedavisi.html
12. Gao J, Huang X, Gu H, Lou L, Xu Z. Predictive criteria of severe cases in COVID-19 patients of early stage: A retrospective observational study. Journal of clinical laboratory analysis . Oct 2020;34(10):e23562. doi:10.1002/jcla.23562
13. Ullah W, Thalambedu N, Haq S, et al. Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19.Journal of community hospital internal medicine perspectives . Sep 3 2020;10(5):402-408. doi:10.1080/20009666.2020.1798141
14. Katzenschlager S, Zimmer AJ, Gottschalk C, et al. Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome? medRxiv : the preprint server for health sciences . Nov 12 2020;doi:10.1101/2020.11.09.20228858
15. Zeng F, Deng G, Cui Y, et al. A predictive model for the severity of COVID-19 in elderly patients. Aging . Nov 10 2020;12(21):20982-20996. doi:10.18632/aging.103980
16. Mudatsir M, Fajar JK, Wulandari L, et al. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Research . 2020;9:1107. doi:10.12688/f1000research.26186.1
17. Ramachandran P, Perisetti A, Gajendran M, Chakraborti A, Narh JT, Goyal H. Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019. Journal of clinical and experimental hepatology . Nov-Dec 2020;10(6):533-539. doi:10.1016/j.jceh.2020.06.009
18. Medetalibeyoglu A, Catma Y, Senkal N, et al. The effect of liver test abnormalities on the prognosis of COVID-19. Annals of hepatology . Nov - Dec 2020;19(6):614-621. doi:10.1016/j.aohep.2020.08.068
19. Ponziani FR, Del Zompo F, Nesci A, et al. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Alimentary pharmacology & therapeutics . Sep 2020;52(6):1060-1068. doi:10.1111/apt.15996
20. Bernal-Monterde V, Casas-Deza D, Letona-Gimenez L, et al. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines . Sep 4 2020;8(9)doi:10.3390/biomedicines8090328
21. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int . Sep 2020;40(9):2095-2103. doi:10.1111/liv.14455
22. Shao T, Tong Y, Lu S, et al. gamma-Glutamyltransferase Elevations Are Frequent in Patients With COVID-19: A Clinical Epidemiologic Study.Hepatology communications . Jul 11 2020;doi:10.1002/hep4.1576
23. Wu Y, Li H, Guo X, et al. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatology international . Sep 2020;14(5):621-637. doi:10.1007/s12072-020-10074-6